DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)

NCT02555943 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Infection
HBV Coinfection
Hepatitis B Reactivation

Interventions

DRUG: Ledipasvir/Sofosbuvir
DRUG: Sofosbuvir and Daclatasvir
DRUG: Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir
DRUG: Entecavir
DRUG: Tenofovir disoproxil

Sponsor

Humanity and Health Research Centre

Collaborators

[object Object]
[object Object]